SARS-CoV-2 IgM/IgG Rapid Test by Colloidal Gold Method

Shanghai Biotecan Pharmaceuticals Co.,Ltd.
A leading enterprise in precision medicine

SARS-CoV-2 IgM/IgG Rapid Test by Colloidal Gold Method


Recommended Applications
  • As an auxiliary diagnosis of COVID-19
  • Combined detection of IgM/IgG antibody and nucleic acid of SARS-CoV-2 can improve the detection rate

Advantages
  1. Rapid
    Instant results in 15 minutes
  2. Easy
    Only 2 steps to operate
  3. Practical
    1 Kit detect IgM and IgG antibodies
  4. Convenient
    No need of any equipments or professionals
  5. Safe
    Blood sample can minimize infection risk
IgM can be detected within one week after infection with slight difference among indi- viduals. IgG appears about 14 days after infection and persists after production, and can be used as an indicator of previous infection. Monitoring both IgM and IgG makes the diagnosis more accurate.

Product Information

Catalogue NO. Product Name Model User Manual Performance Evaluation Data
BT2020-003 SARS-CoV-2 IgM/IgG Rapid Test by Colloidal Gold Method 50T

* Tests have been validated but FDA's independent review of this validation is pending.





CE




About us
At Shanghai Biotecan Pharmaceuticals Co.,Ltd., our mission is to provide the best healthcare services and products through the most advanced technology. The company’s goal is to empower every medical professional and patient with systematic precision medicine solutions. Biotecan uses strict quality management control system and strictly follows China’s GLP & GMP standards. The company has over 60 clinical molecular diagnostic laboratories across China and two affiliated GMP facilities located in Shanghai and currently provides over 2000 different types of clinical testing services and 11 medical devices and diagnostic reagents.





Shanghai Biotecan Pharmaceuticals Co.,Ltd.
Address:First Shanghai Centre, 180 Zhangheng Rd., Pudong New District, Shanghai, China
Tel:+86-21-50277725
www.biotecan.com